Metformin is associated with a reduced risk of mortality in patients

The 7th scientific article published in Diabetes & Metabolism by the CORONADO initiative points out that metformin (the reference treatment for type 2 diabetes) is associated with a mortality risk reduction of approximately 1/3 in type 2 diabetic patients hospitalized for COVID-19.